Literature DB >> 8020668

Protective role of biliary cholesterol and phospholipid lamellae against bile acid-induced cell damage.

L Puglielli1, L Amigo, M Arrese, L Núñez, A Rigotti, J Garrido, S González, G Mingrone, A V Greco, L Accatino.   

Abstract

BACKGROUND/AIMS: Bile salts (BS) are cytotoxic agents, but cell damage is not observed in the hepatobiliary system. We hypothesized that biliary lipid vesicles (unilamellae and multilamellae) could have a protective role against BS-induced cytotoxicity.
METHODS: Biliary lipid lamellar secretion was induced by feeding rats with 0.5% diosgenin. Cytoprotection was assessed in bile duct-obstructed rats and by incubating human erythrocytes with sodium taurocholate.
RESULTS: Biliary cholesterol concentration increased > 300% in diosgenin-fed rats; electron microscopic examination showed a great abundance of lipid lamellar vesicles in bile and within the canaliculi. After bile duct obstruction, serum hepatic enzyme activities were significantly lower in diosgenin-fed rats. Histologically severe and confluent hepatocellular necrosis was only observed in control rats. Biliary lamellar lipid material significantly reduced the BS-induced hemolytic effect in vitro in a concentration-dependent manner. This protective effect correlated to a progressive decrease in the intermicellar BS concentration. Phosphatidylcholine or cholesterol, alone or as lamellar structures, also showed cytoprotective effect in vitro but always less than native biliary lamellae.
CONCLUSIONS: These results support the concept that native biliary cholesterol phospholipid lamellae represent an important cytoprotective factor for hepatocytes and biliary epithelial cells against BS-induced damage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8020668     DOI: 10.1016/0016-5085(94)90083-3

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  9 in total

1.  A "forward genomics" approach links genotype to phenotype using independent phenotypic losses among related species.

Authors:  Michael Hiller; Bruce T Schaar; Vahan B Indjeian; David M Kingsley; Lee R Hagey; Gill Bejerano
Journal:  Cell Rep       Date:  2012-09-27       Impact factor: 9.423

Review 2.  Bile acid interactions with cholangiocytes.

Authors:  Xuefeng Xia; Heather Francis; Shannon Glaser; Gianfranco Alpini; Gene LeSage
Journal:  World J Gastroenterol       Date:  2006-06-14       Impact factor: 5.742

3.  Modulation of intrahepatic cholesterol trafficking: evidence by in vivo antisense treatment for the involvement of sterol carrier protein-2 in newly synthesized cholesterol transport into rat bile.

Authors:  L Puglielli; A Rigotti; L Amigo; L Nuñez; A V Greco; M J Santos; F Nervi
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

4.  Stimulation of ABCB4/MDR3 ATPase activity requires an intact phosphatidylcholine lipid.

Authors:  Martin Prescher; Sander H J Smits; Lutz Schmitt
Journal:  J Lipid Res       Date:  2020-09-11       Impact factor: 5.922

5.  Mucus production of choledochal epithelial cells due to bile stagnation in the rat.

Authors:  K Kurumado; T Nagai; H Abe
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

6.  Anti-inflammatory effects of phosphatidylcholine.

Authors:  Irina Treede; Annika Braun; Richard Sparla; Mark Kühnel; Thomas Giese; Jerrold R Turner; Elsa Anes; Hasan Kulaksiz; Joachim Füllekrug; Wolfgang Stremmel; Gareth Griffiths; Robert Ehehalt
Journal:  J Biol Chem       Date:  2007-07-18       Impact factor: 5.157

7.  Fibrates induce mdr2 gene expression and biliary phospholipid secretion in the mouse.

Authors:  J Chianale; V Vollrath; A M Wielandt; L Amigo; A Rigotti; F Nervi; S Gonzalez; L Andrade; M Pizarro; L Accatino
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

8.  Cholesterol attenuates cytoprotective effects of phosphatidylcholine against bile salts.

Authors:  Yoshito Ikeda; Shin-Ya Morita; Tomohiro Terada
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

9.  Comparison of Laboratory Data of Acute Cholangitis Patients Treated with or without Immunosuppressive Drugs.

Authors:  Minoru Tomizawa; Fuminobu Shinozaki; Rumiko Hasegawa; Yoshinori Shirai; Noboru Ichiki; Yasufumi Motoyoshi; Takao Sugiyama; Shigenori Yamamoto; Makoto Sueishi
Journal:  ISRN Gastroenterol       Date:  2014-03-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.